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ABSTRACT 
Epithelial Ovarian Cancer (EOC) is a malignant cancer with high mortality among 
Indonesian women. EOC showed no specific symptoms in its early stages, 
thus making the screening mostly occur when patients are in advanced stage. 
Treatment of advance-stage EOC is more challenging and prognosis is poor. 
Therefore, minimally-invasive biomarkers are needed to diagnose at the early 
stage. microRNA is one of the potential biomarkers which not only expressed 
inside the cell, but also secreted outside the cell with exosome protection. This 
protection makes microRNA stable. Moreover, several studies have shown the 
ability to detect microRNA in the blood sample. microRNA-21 (miR-21) is oncomiR 
targeting tumor suppressor mRNA RECK based on in-silico analysis. 
The first aim of this study is to determine the expression of miR-21 in plasma 
samples of EOC patients compared to healthy controls. The second aim is to 
investigate the expression correlation between miR-21 and RECK mRNA. 
Blood samples were collected from 30 patients and 30 healthy controls. Plasma 
was then obtained from centrifuged blood samples. The total RNA was isolated 
and reverse transcribed to produce cDNAs. cDNAs were then quantified using 
qPCR using specific primer for miR-21 and RECK mRNA. The expression analysis 
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was done using relative expression method by Livak. The expression of miR-21 
was calculated using the miR-16 expression as the reference gene. Also, Beta-
actin was used as reference gene for RECK mRNA calculation. The correlation 
between the expression of miR-21 and mRNA RECK was analyzed using the 
Spearman rho correlation analysis. 
This study revealed that the expression of miR-21 in EOC patients increased 
4.7579-fold compared to healthy controls (p <0.05). On the other hand, the 
miR-21 target, RECK mRNA, decreased 4,2 times with fold change 0.237665 on 
plasma of EOC patients compared to healthy controls (p <0.05). The statistical 
calculation of the expression of miR-21 and mRNA RECK was inversely proportional 
to mRNA RECK with a strong correlation. 
This study was able to prove that the expression of miR-21 is upregulated in EOC 
patients and confirmed by the downregulation of RECK expression. The future 
research to design anti-miR-21 and suppress the expression of miR-21 in EOC is 
required, and analysis of the effect of miR-21 in the development of EOC might 
also be performed. 
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